WILTROM CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 36.15 TWD | -0.55% |
|
-0.28% | +0.28% |
| 15/05 | Wiltrom Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 26/02 | Wiltrom Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Sales 2022 | 207M 6.4M 535M | Sales 2023 | 283M 8.74M 730M | Capitalization | 1.05B 32.46M 2.71B |
|---|---|---|---|---|---|
| Net income 2022 | -17M -526K -43.93M | Net income 2023 | 1M 30.93K 2.58M | EV / Sales 2022 | 4.07 x |
| Net cash position 2022 | 66.83M 2.07M 173M | Net cash position 2023 | 72.34M 2.24M 187M | EV / Sales 2023 | 3.46 x |
| P/E ratio 2022 |
-53.5
x | P/E ratio 2023 |
706
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 50.81% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.55% | ||
| 1 week | -0.28% | ||
| Current month | -1.50% | ||
| 1 month | -2.95% | ||
| 3 months | -2.30% | ||
| 6 months | +5.09% | ||
| Current year | +0.28% |
1 week
35.50
36.90
1 month
35.5038.10
Current year
33.8042.90
1 year
32.6050.00
3 years
25.2550.00
5 years
21.0054.00
10 years
21.0054.00
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 29/09/29 | |
Hui Wen Hsiao
DFI | Director of Finance/CFO | - | 01/19/01 |
I Chun Su
BRD | Director/Board Member | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Chao Hsun Chung
BRD | Director/Board Member | - | - |
Chih Yuan Yu
BRD | Director/Board Member | - | - |
Chun Nan Lin
BRD | Director/Board Member | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/24/13 | 36.15 | -0.55% | 40,327 |
| 12/24/12 | 36.35 | +0.41% | 67,306 |
| 11/24/11 | 36.2 | +0.14% | 33,001 |
| 07/24/07 | 36.15 | +1.69% | 27,041 |
| 06/24/06 | 35.55 | -1.93% | 35,028 |
End-of-day quote Taipei Exchange, June 13, 2024
More quotes
Wiltrom Co., Ltd. is a Taiwan-based company mainly engaged in the development, manufacture and sale of spinal fusion surgery products. The main products are spinal fixators, artificial bones and interbody fusion cages. The Company's products are mainly focused on three parts including spinal fusion surgery related products, spinal compression fracture surgery products and bone cement products. The Company distributes its products mainly in Taiwan, Asia, America and other places.
| 1st Jan change | Capi. | |
|---|---|---|
| +0.28% | 32.82M | |
| -6.01% | 182B | |
| -0.87% | 108B | |
| -4.86% | 67.62B | |
| -8.28% | 46.61B | |
| +13.07% | 45.32B | |
| +6.47% | 42.11B | |
| +21.56% | 31.17B | |
| +13.26% | 25.66B | |
| -4.50% | 24.65B |
- Stock Market
- Equities
- 6767 Stock
